• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

H1N1 Microneedle Vaccine Protects Better Than Injection

tetano

Editor, Senior Moderator
A vaccine delivered to the skin using a microneedle patch gives better protection against the H1N1 influenza virus than a vaccine delivered through subcutaneous or intramuscular injection, researchers from Emory and Georgia Tech have found. Their research is published online in the Journal of Infectious Diseases.

Mice given a single H1N1 vaccine through the skin using a coated metal microneedle patch as well as mice vaccinated through subcutaneous injection were 100 percent protected against a lethal flu virus challenge six weeks after vaccination. However, when challenged with the H1N1 virus six months later, the injected mice had a 60 percent decrease in antibody production against the virus and extensive lung inflammation. Mice that were vaccinated with microneedles, on the other hand, maintained high levels of protection and antibody production after six months, with no signs of lung inflammation.

?A major goal of influenza vaccine development has been to confer strong immune responses, including immunological memory and cellular immune responses for long-term protection, and to limit virus spread after infection,? says first author Dimitrios Koutsonanos, MD, post-doctoral fellow of microbiology and immunology at Emory University School of Medicine.

..

http://shared.web.emory.edu/whsc/ne...-vaccine-protects-better-than-injection-.html
 
Back
Top